Dashboard
Manage Tickers

MISTMilestone Pharmaceuticals Inc.

Nasdaq milestonepharma.com


$ 1.40 $ -0.01 (-0.71 %)    

Friday, 09-Aug-2024 10:14:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 448.41 $ 2.64 (0.59 %)
DIA $ 394.35 $ 0.80 (0.2 %)
SPY $ 530.77 $ 2.14 (0.4 %)
TLT $ 96.34 $ 0.19 (0.2 %)
GLD $ 224.63 $ -0.20 (-0.09 %)
$ 1.41
$ 1.41
$ 1.41 x 100
$ 1.41 x 100
$ 1.40 - $ 1.41
$ 1.12 - $ 3.62
144,883
na
75.11M
$ 0.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-29-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-24-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-29-2021 12-31-2020 10-K
16 11-13-2020 09-30-2020 10-Q
17 08-12-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-06-2020 12-31-2019 10-K
20 11-13-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 06-19-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

milestone-pharmaceuticals-q2-2024-adj-eps-014-beats-019-estimate
Milestone Pharmaceuticals Q2 2024 Adj EPS ...
08/08/2024 21:45:24

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimat...

hc-wainwright--co-reiterates-buy-on-milestone-pharmaceuticals-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on Mile...
07/01/2024 17:41:43

HC Wainwright & Co. analyst Patrick Trucchio reiterates Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and maintains...

hc-wainwright--co-reiterates-buy-on-milestone-pharmaceuticals-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on Mile...
05/30/2024 11:13:51

HC Wainwright & Co. analyst Patrick Trucchio reiterates Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and maintains...

fda-accepts-milestone-pharmaceuticals-new-drug-application-for-cardamyst-etripamil-nasal-spray-to-manage-paroxysmal-supraventricular-tachycardia-prescription-drug-user-fee-act-is-10-months-from-the-acceptance-date-of-may-26-2024
FDA Accepts Milestone Pharmaceuticals' New...
05/29/2024 11:05:19

hc-wainwright--co-reiterates-buy-on-milestone-pharmaceuticals-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on Mile...
05/16/2024 11:52:34

HC Wainwright & Co. analyst Patrick Trucchio reiterates Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and maintains...

milestone-pharmaceuticals-says-cash-resources-as-of-march-31-2024-of-895m-is-expected-to-fund-operations-into-2026
Milestone Pharmaceuticals Says Cash Resour...
05/13/2024 11:22:04

milestone-pharmaceuticals-q1-2024-gaap-eps-021-beats-024-estimate
Milestone Pharmaceuticals Q1 2024 GAAP EPS...
05/13/2024 11:20:41

milestone-pharmaceuticals-to-present-data-on-etripamil-at-the-preventative-cardiovascular-nursing-symposium
Milestone Pharmaceuticals To Present Data ...
04/17/2024 12:12:17

Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of i...

milestone-pharmaceuticals-announces-etripamil-data-demonstrating-patients-ability-to-self-manage-recurring-psvt-presented-at-the-american-college-of-cardiology-annual-meeting
Milestone Pharmaceuticals Announces Etripa...
04/08/2024 15:37:40

Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of i...

milestone-pharmaceuticals-to-present-data-on-etripamil-at-the-american-college-of-cardiology-and-european-heart-rhythm-association-annual-conferences
Milestone Pharmaceuticals To Present Data ...
04/01/2024 12:02:20

Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of i...

milestone-pharmaceuticals-disclosed-resubmission-of-new-drug-application-for-etripamil-for-treatment-in-paroxysmal-supraventricular-tachycardia
Milestone Pharmaceuticals Disclosed Resubm...
03/28/2024 11:17:25

hc-wainwright--co-reiterates-buy-on-milestone-pharmaceuticals-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on Mile...
03/22/2024 18:07:16

HC Wainwright & Co. analyst Patrick Trucchio reiterates Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and maintains...

milestone-pharmaceuticals-q4-earnings-insights
Milestone Pharmaceuticals: Q4 Earnings Ins...
03/21/2024 13:10:11

milestone-pharmaceuticals-q4-gaap-eps-032-misses-031-estimate-cash-balance-of-66m-expected-to-provide-cash-runway-into-2026
Milestone Pharmaceuticals Q4 GAAP EPS $(0....
03/21/2024 11:20:35

aMilestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.32) per share which missed the analyst consensus esti...

piper-sandler-maintains-overweight-on-milestone-pharmaceuticals-lowers-price-target-to-5
Piper Sandler Maintains Overweight on Mile...
03/05/2024 14:05:33

Piper Sandler analyst Edward Tenthoff maintains Milestone Pharmaceuticals (NASDAQ:MIST) with a Overweight and lowers the pri...

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
02/29/2024 13:07:01

why-okta-shares-are-trading-higher-by-around-24-here-are-20-stocks-moving-premarket
Why Okta Shares Are Trading Higher By Arou...
02/29/2024 13:04:20

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-e...

milestone-pharmaceuticals-priced-its-public-offering-of-167m-shares-at-150share-and-pre-funded-warrants-to-purchase-33m-shares-at-149pre-funded-warrant-with-gross-proceeds-of-approximately-30m
Milestone Pharmaceuticals Priced Its Publi...
02/29/2024 12:18:41

milestone-pharmaceuticals-announces-proposed-public-offering-of-common-shares-and-pre-funded-warrants
Milestone Pharmaceuticals Announces Propos...
02/28/2024 21:51:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION